Bioelectric Wound Care Opportunity to expand into hospitals and clinics focusing on wound care, leveraging V.Dox technology and Procellera products to reduce infection and accelerate healing, especially where antibiotic resistance is a concern.

OTC and PPE Expansion Recent OTC bioelectric bandage launch suggests potential for retail and consumer health channels; explore partnerships with medical supply distributors and PPE manufacturers to extend reach into home care and outpatient settings.

Biofilm Disruption Advantage Position V.Dox technology as a differentiator in infection control portfolios, targeting facilities with biofilm-related infection challenges and where there is a push for non-antibiotic antimicrobial solutions.

Strategic Partnerships Leverage past collaborations (University of Miami Health System, Lucintel) to secure new research or co-development deals, emphasizing clinical validation and case studies to accelerate procurement conversations.

Funding and Growth Potential With capital raised and a small team, present the company as an agile partner for pilot programs, enabling fast cycles from trial to deployment in mid to large healthcare systems and specialized wound care centers.